Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: Analysis of pooled data from MDACC and MSKCC

Journal of Clinical Oncology

Volumn 26, Issue 1, 2008, Pages 121-126

  Kassouf, Wassim ^a   Agarwal, Piyush K ^a   Herr, Harry W ^a   Munsell, Mark F ^a   Spiess, Philippe E ^a   Brown, Gordon A ^a   Pisters, Louis ^a   Grossman, H Barton ^a   Dinney, Colin P ^a   Kamat, Ashish M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FOLLOW UP; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 37849006828     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.9247     Document Type: Article

References (15)

1. Stein JP, Lieskovsky G, Cote R, et al: Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19:666-675, 2001
2. Greene FL, Page DL, Fleming ID, et al: AJCC Cancer Staging Manual (ed 6). New York, NY, Springer-Verlag, 2002
3. Frank I, Cheville JC, Blute ML, et al: Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: Clinicopathologic features associated with outcome. Cancer 97:2425-2431, 2003
4. Abdel-Latif M, Abol-Enein H, El-Baz M, et al: Nodal involvement in bladder cancer cases treated with radical cystectomy: Incidence and prognosis. J Urol 172:85-89, 2004
5. Herr HW: Superiority of ratio based lymph node staging for bladder cancer. J Urol 169:943-945, 2003
6. Kassouf W, Leibovici D, Munsell MF, et al: Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 176:53-57, 2006
7. Stein JP, Cai J, Groshen S, et al: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: The concept of lymph node density. J Urol 170:35-41, 2003
8. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457-481, 1958
9. Cox DR: Regression models and life tables (with discussion). J Roy Statist Soc B 34:187-220, 1972
10. Smith JA Jr, Whitmore WF Jr: Regional lymph node metastasis from bladder cancer. J Urol 126:591-593, 1981
11. Fleischmann A, Thalmann GN, Markwalder R, et al: Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Onc 23:2358-2365, 2005
12. Vieweg J, Gschwend JE, Herr HW, et al: Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 161:449-454, 1999
13. Herr HW, Bochner BH, Dalbagni G, et al: Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295-1298, 2002
14. Herr HW: The concept of lymph node density - is it ready for clinical practice? J Urol 177:1273-1276, 2007
15. Weingartner K, Ramaswamy A, Bittinger A, et al: Anatomical basis for pelvic lymphadenectomy in prostate cancer: Results of an autopsy study and implications for the clinic. J Urol 156:1969-1971, 1996